Browsing: Approval

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition.

Market snapshot: Sun Pharmaceutical Industries Limited has obtained regulatory approval from the South African Health Products Regulatory Authority (SAHPRA) to manufacture and market a generic version of semaglutide injection in South Africa, expanding its global footprint in the metabolic and diabetes therapy segment (Source: NSE India, 15 Jul 2026, https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFhYeBDvjMV-vCkAASidsCo5XFAIUZFtauU92vnQAvq3hkAtULKTI_eJjjb26gLaOCZkymJD7e-On0gl9Kt3qx8DHXAsH5dC8n2-5zTthk8RY2ekI_JaCOvtAKyPzxnDg0KsHE9D86bcUopAxkhmS5pEHjeRBzaCjwsDks8aTgB5ysfnLHhVLKRbq2X8SNpyenzJ-mcxFN7evYoT1b2ulY-). This marks the second market…